GO:0050922 negative regulation of chemotaxis: Signaling Brakes, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0050922 describes any process that stops, prevents, or reduces the frequency, rate, or extent of directed cell or organism movement along a chemical gradient.
• Negative regulation of chemotaxis is essential for confining immune cells to sites of inflammation and preventing excessive tissue infiltration.
• Key molecular brakes include the lipid phosphatase activity of PTEN, which dephosphorylates PIP3 to terminate CXCR4-mediated chemotaxis.
• The adaptor protein p66Shc negatively regulates chemokine receptor signaling and B-cell chemotaxis, illustrating layer-specific control.
• Loss of negative regulators such as ARID1A can unleash polymorphonuclear myeloid-derived suppressor cell chemotaxis and promote prostate cancer progression.
• Bacterial chemotaxis is also subject to negative regulation by environmental nitrogen sources, showing the term spans prokaryotes and eukaryotes.
Description
Chemotaxis is the directed movement of cells or organisms along a chemical concentration gradient, a process fundamental to immune surveillance, development, and microbial survival. However, uncontrolled chemotaxis can drive pathological inflammation, cancer metastasis, and autoimmune tissue damage. To prevent such outcomes, cells employ dedicated molecular circuits that stop, prevent, or reduce the frequency, rate, or extent of chemotactic movement. This biological process is formally annotated as GO:0050922, negative regulation of chemotaxis. Understanding this term is critical for researchers dissecting how signaling pathways are switched off, how immune cell trafficking is confined, and how pathogens modulate their motility. The negative regulation of chemotaxis operates through diverse mechanisms, including lipid phosphatase activity that degrades chemoattractant-generated second messengers, adaptor proteins that dampen chemokine receptor signaling, and environmental cues that override chemotactic drives. For example, PTEN terminates CXCR4-mediated chemotaxis by dephosphorylating phosphatidylinositol (3,4,5)-trisphosphate (PIP3), thereby opposing PI3K signaling. Similarly, p66Shc acts as a negative regulator of chemokine receptor signaling in B cells, limiting their migration. In bacteria such as Pseudomonas aeruginosa, the availability of nitrogen sources negatively regulates chemotaxis, linking nutrient status to motility. For biomedical researchers, GO:0050922 provides a framework to study how cells put the brakes on migration. Dysregulation of these brakes contributes to cancer progression, chronic inflammation, and immune disorders. This article synthesizes authoritative QuickGO annotation data and verified PubMed literature to explain the definition, mechanisms, key genes, disease links, and experimental models for studying negative regulation of chemotaxis.
negative regulation of chemotaxis At A Glance
| GO ID | GO:0050922 |
|---|---|
| GO term | negative regulation of chemotaxis |
| Ontology | biological_process |
| Synonym | down regulation of chemotaxis, down-regulation of chemotaxis, downregulation of chemotaxis, inhibition of chemotaxis |
| Major function | Stops, prevents, or reduces the directed movement of a motile cell or organism along a chemical concentration gradient. |
| Regulatory level | Can act on chemoattractant receptors, second messengers, or cytoskeletal effectors. |
| Example regulators | PTEN, p66Shc, ARID1A, and environmental nitrogen sources. |
| Taxonomic scope | Eukaryotic cells (e.g., immune cells, cancer cells) and prokaryotes (e.g., Pseudomonas aeruginosa). |
| Related process | Chemotaxis (GO:0006935) and positive regulation of chemotaxis (GO:0050921). |
What Is GO:0050922?
According to the Gene Ontology, GO:0050922 (negative regulation of chemotaxis) is defined as any process that stops, prevents, or reduces the frequency, rate, or extent of the directed movement of a motile cell or organism in response to a specific chemical concentration gradient. In simpler terms, it is the set of biological mechanisms that put the brakes on chemotaxis, ensuring that cells do not over-migrate toward a chemical signal. This regulation can occur at multiple levels, including receptor desensitization, degradation of chemoattractant second messengers, and modulation of downstream cytoskeletal dynamics.
Why Is negative regulation of chemotaxis Important in Cell Biology?
Negative regulation of chemotaxis is essential for maintaining tissue homeostasis and preventing pathological cell migration. Without these brakes, immune cells would continuously infiltrate tissues, leading to chronic inflammation and autoimmunity. In cancer, loss of negative regulators such as PTEN or ARID1A can enhance chemotaxis of malignant cells or immunosuppressive myeloid cells, promoting metastasis and tumor progression. In infectious disease, bacterial chemotaxis is negatively regulated by nutrient availability, affecting pathogen colonization. Thus, understanding GO:0050922 provides mechanistic insights into diseases and identifies potential therapeutic targets.
• Prevents excessive immune cell infiltration and tissue damage during inflammation.
• Controls cancer cell chemoinvasion and metastasis by terminating chemokine receptor signaling.
• Regulates B-cell trafficking and humoral immune responses through p66Shc.
• Modulates tumor microenvironment by limiting myeloid-derived suppressor cell chemotaxis.
• Influences bacterial pathogenesis by linking nitrogen metabolism to motility.
• Provides targets for anti-inflammatory and anti-metastatic therapies.
• Helps explain how cells prioritize directional migration versus other functions.
• Serves as a model for studying signal termination and adaptation in chemotaxis.
What Happens During negative regulation of chemotaxis?
Receptor desensitization and internalization
In simple terms: Cells turn off the receptors that sense chemical signals.
Negative regulation of chemotaxis often begins at the level of chemoattractant receptors. For example, p66Shc negatively regulates chemokine receptor signaling in B cells, reducing their chemotactic response. Similarly, the platelet-derived growth factor receptor-beta (PDGFR-beta) is subject to regulation that can dampen chemotaxis. Receptor desensitization involves phosphorylation, arrestin recruitment, and internalization, which collectively reduce the cell's sensitivity to the gradient.
Degradation of second messengers
In simple terms: Enzymes destroy the molecular signals that tell cells to move.
The lipid phosphatase activity of PTEN negatively regulates CXCR4-mediated chemotaxis by dephosphorylating PIP3, the second messenger generated by PI3K. This degradation of PIP3 terminates downstream Akt signaling and actin polymerization, effectively stopping directed migration. Thus, second messenger turnover is a central mechanism for negative regulation of chemotaxis.
Modulation of cytoskeletal dynamics
In simple terms: The cell's internal skeleton is reorganized to stop movement.
Chemotaxis requires polarized actin polymerization at the leading edge. Negative regulation can disrupt this polarity by inhibiting Rho GTPases or activating phosphatases that depolymerize actin. For instance, PTEN-mediated PIP3 depletion reduces Rac activation, leading to loss of lamellipodia and cessation of migration. This cytoskeletal brake ensures that cells can reverse or halt migration when appropriate.
Environmental and metabolic cues
In simple terms: External conditions like nutrient availability can override the urge to move.
In bacteria, the nitrogen source negatively regulates chemotaxis in Pseudomonas aeruginosa; when preferred nitrogen sources are available, chemotaxis is suppressed. This integration of metabolic status with motility allows organisms to conserve energy and prioritize growth. Similarly, in eukaryotic cells, purinergic signaling can modulate chemotaxis during airway inflammation.
Transcriptional and epigenetic control
In simple terms: Cells can change gene expression to reduce their ability to migrate.
Long-term negative regulation of chemotaxis can occur through transcriptional changes. For example, ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis, indicating that chromatin remodeling complexes normally suppress pro-migratory gene programs. This epigenetic layer provides a sustained brake on chemotaxis.
Key Genes Involved in GO:0050922 negative regulation of chemotaxis
The following genes and proteins have been experimentally implicated in the negative regulation of chemotaxis, based on verified PubMed literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PTEN | Lipid phosphatase that degrades PIP3 to terminate CXCR4-mediated chemotaxis | Tumor suppressor; loss enhances chemotaxis and metastasis |
| p66Shc | Adaptor protein that negatively regulates chemokine receptor signaling and B-cell chemotaxis | Modulates immune cell trafficking and oxidative stress |
| ARID1A | Chromatin remodeler whose loss induces PMN-MDSC chemotaxis | Epigenetic regulator of immunosuppressive cell migration in cancer |
| CXCR4 | Chemokine receptor whose signaling is negatively regulated by PTEN | Target in cancer and inflammation |
| PDGFR-beta | Receptor tyrosine kinase regulated to dampen chemotaxis | Model for growth factor receptor control of migration |
| PI3K | Generates PIP3; opposed by PTEN to negatively regulate chemotaxis | Central node in chemotactic signaling |
| Rac | Rho GTPase promoting actin polymerization; inhibited by PIP3 depletion | Cytoskeletal effector in chemotaxis |
| Akt | Downstream kinase of PIP3; its termination reduces chemotaxis | Survival and migration signaling |
| P2Y receptors | Purinergic receptors modulating airway inflammation and chemotaxis | Potential targets in inflammatory lung disease |
| Nitrogen regulatory proteins | Mediate negative regulation of bacterial chemotaxis by nitrogen source | Bacterial pathogenesis and motility |
| Chemokine receptors (general) | Desensitized to reduce chemotaxis | Broad relevance to immune cell migration |
| Arrestins | Scaffold proteins that desensitize chemokine receptors | Regulate receptor internalization |
| GRK kinases | Phosphorylate activated receptors to promote desensitization | Initiate negative regulation of chemotaxis |
| Rho GTPases | Modulate actin dynamics to halt migration | Cytoskeletal control |
| PTEN-associated proteins | Modulate PTEN activity in chemotaxis | Signaling complexes |
| p66Shc isoforms | Alternatively spliced variants with distinct roles | Isoform-specific regulation |
How Is negative regulation of chemotaxis Regulated?
Negative regulation of chemotaxis is itself subject to regulation by upstream signaling pathways. For example, the lipid phosphatase activity of PTEN is controlled by phosphorylation, oxidation, and localization, which in turn determine the extent of CXCR4-mediated chemotaxis inhibition. p66Shc activity is modulated by phosphorylation and oxidative stress, affecting B-cell chemotaxis. In bacteria, nitrogen availability directly regulates chemotaxis through the nitrogen regulatory system. Additionally, purinergic signaling via P2Y receptors can modulate airway inflammation and chemotaxis. These layers of regulation ensure that chemotaxis is finely tuned to physiological context.
negative regulation of chemotaxis and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PTEN | Breast cancer metastasis; enhanced CXCR4 chemotaxis | PTEN knockout breast cancer cell lines; chemotaxis assays |
| ARID1A | Prostate cancer progression; PMN-MDSC chemotaxis | ARID1A knockout mouse models; MDSC migration assays |
| p66Shc | B-cell trafficking and autoimmunity | p66Shc knockout mice; B-cell chemotaxis assays |
| CXCR4 | Cancer metastasis and inflammation | CXCR4 overexpression or knockout cell lines; chemoinvasion assays |
| P2Y receptors | Airway inflammation (asthma, COPD) | P2Y receptor knockout mice; airway inflammation models |
Cancer progression and metastasis
Loss of negative regulators of chemotaxis contributes to cancer progression. PTEN deletion or inactivation enhances CXCR4-mediated chemotaxis and chemoinvasion in breast cancer cells, promoting metastasis. Similarly, ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis, creating an immunosuppressive tumor microenvironment that accelerates prostate cancer progression. These findings highlight negative regulation of chemotaxis as a barrier against malignant spread.
Chronic inflammation and autoimmune disease
Inadequate negative regulation of chemotaxis leads to excessive immune cell infiltration. p66Shc negatively regulates B-cell chemotaxis, and its dysfunction may contribute to autoimmune conditions characterized by aberrant B-cell trafficking. Purinergic regulation of airway inflammation involves modulation of chemotaxis, and its dysregulation can exacerbate asthma and COPD. Thus, restoring chemotactic brakes is a potential anti-inflammatory strategy.
Bacterial infections and pathogenesis
In Pseudomonas aeruginosa, the nitrogen source negatively regulates chemotaxis, affecting the bacterium's ability to colonize host tissues. Understanding this regulation can inform strategies to interfere with bacterial motility and biofilm formation. The principles of negative regulation of chemotaxis are therefore relevant to infectious disease research.
From negative regulation of chemotaxis-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PTEN lipid phosphatase activity negatively regulate CXCR4-mediated chemotaxis? | PTEN knockout and catalytically dead PTEN knock-in cell lines |
| How does p66Shc limit B-cell chemotaxis? | p66Shc knockout mice and B-cell chemotaxis assays |
| Does ARID1A loss enhance PMN-MDSC chemotaxis? | ARID1A conditional knockout mice and MDSC migration assays |
| What is the role of PDGFR-beta in negative regulation of chemotaxis? | PDGFR-beta knockout or point-mutant fibroblasts; chemotaxis assays |
| How does nitrogen source regulate bacterial chemotaxis? | Pseudomonas aeruginosa nitrogen regulatory mutants; chemotaxis plate assays |
| Can overexpression of a negative regulator suppress chemotaxis? | Overexpression cell lines (e.g., PTEN, p66Shc) and chemotaxis assays |
How to Study the negative regulation of chemotaxis Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Transwell chemotaxis assay | Directed cell migration toward a chemoattractant | Quantifying negative regulation by PTEN or p66Shc |
| Microfluidic chemotaxis | Real-time migration in controlled gradients | Studying cell polarity and adaptation |
| Live-cell imaging with PIP3 biosensor | PIP3 dynamics at the leading edge | Visualizing PTEN-mediated termination of chemotaxis |
| Western blot for phospho-Akt | Activation status of downstream signaling | Assessing CXCR4 signaling inhibition |
| CRISPR knockout screen | Genes whose loss enhances chemotaxis | Discovery of novel negative regulators |
| Bacterial chemotaxis plate assay | Motility of Pseudomonas aeruginosa | Testing nitrogen source regulation |
| Immunoprecipitation | Protein-protein interactions in chemotaxis | Studying p66Shc complexes |
| Flow cytometry | Immune cell migration and phenotype | Analyzing B-cell chemotaxis |
Chemotaxis assays (Transwell and microfluidic)
Transwell and microfluidic chemotaxis assays are standard for measuring directed cell migration. They allow quantification of the frequency, rate, and extent of chemotaxis in response to a chemical gradient. These assays are used to test negative regulators by comparing wild-type and knockout cells.
Live-cell imaging and biosensors
Live-cell imaging with fluorescent biosensors (e.g., PIP3 biosensors) visualizes second messenger dynamics during chemotaxis. This method reveals how negative regulators such as PTEN terminate PIP3 signaling at the leading edge. It also tracks cytoskeletal changes in real time.
Biochemical assays for receptor signaling
Western blotting, immunoprecipitation, and kinase assays measure phosphorylation events in chemokine receptor signaling. These techniques assess receptor desensitization and downstream pathway inhibition, providing mechanistic insights into negative regulation.
Genetic screens and CRISPR libraries
CRISPR knockout libraries enable unbiased discovery of negative regulators of chemotaxis. By screening for enhanced migration, researchers can identify novel brakes on chemotaxis. This approach has been used to uncover genes like ARID1A.
How CRISPR Can Be Used to Study GO:0050922 negative regulation of chemotaxis
Knockout
CRISPR knockout of negative regulators such as PTEN or ARID1A can enhance chemotaxis, providing causal evidence for their role. For example, PTEN knockout increases CXCR4-mediated chemotaxis in cancer cells. ARID1A knockout induces PMN-MDSC chemotaxis in prostate cancer models.
Point Mutation
Point mutations can dissect specific domains. A catalytically dead PTEN point mutant (e.g., C124S) abolishes lipid phosphatase activity, preventing negative regulation of chemotaxis. Such models distinguish enzymatic from scaffolding functions.
Knock-in
Knock-in of tagged or fluorescently labeled proteins (e.g., GFP-PTEN) allows real-time tracking of negative regulators during chemotaxis. This approach reveals subcellular localization and dynamics.
Overexpression
Overexpression of negative regulators such as p66Shc or PTEN can suppress chemotaxis, confirming their inhibitory role. Overexpression models are useful for testing therapeutic potential.
How EDITGENE Supports negative regulation of chemotaxis Research
Researchers studying negative regulation of chemotaxis-related genes often need to determine whether a candidate gene is causally involved in braking cell migration. This requires precise genetic models that can knockout, mutate, tag, or overexpress the gene of interest in relevant cell types. EDITGENE provides end-to-end CRISPR services to accelerate such discoveries.
Contact EDITGENE today to design your custom CRISPR model for negative regulation of chemotaxis research.
Frequently Asked Questions About negative regulation of chemotaxis
What is negative regulation of chemotaxis (GO:0050922)?
It is any process that stops, prevents, or reduces the frequency, rate, or extent of directed cell movement along a chemical gradient.
What genes are involved in negative regulation of chemotaxis?
Key genes include PTEN, p66Shc, ARID1A, and CXCR4, among others.
How does PTEN negatively regulate chemotaxis?
PTEN dephosphorylates PIP3, terminating CXCR4-mediated signaling and actin polymerization.
What is the role of p66Shc in chemotaxis?
p66Shc negatively regulates chemokine receptor signaling and B-cell chemotaxis.
Can loss of ARID1A affect chemotaxis?
Yes, ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression.
Is negative regulation of chemotaxis relevant to cancer?
Yes, loss of negative regulators like PTEN enhances cancer cell chemoinvasion and metastasis.
How is bacterial chemotaxis negatively regulated?
In Pseudomonas aeruginosa, the nitrogen source negatively regulates chemotaxis.
What experimental methods study negative regulation of chemotaxis?
Transwell assays, live-cell imaging, CRISPR screens, and biochemical assays are commonly used.
What are synonyms for GO:0050922?
Synonyms include down regulation of chemotaxis, down-regulation of chemotaxis, downregulation of chemotaxis, and inhibition of chemotaxis.
How can CRISPR help study negative regulation of chemotaxis?
CRISPR knockout, point mutation, knock-in, and overexpression models can test causal roles of candidate genes.
Conclusion
GO:0050922 negative regulation of chemotaxis is a critical biological process that puts the brakes on directed cell migration. Through mechanisms such as PTEN-mediated PIP3 degradation, p66Shc-dependent receptor desensitization, and ARID1A-controlled epigenetic programs, cells prevent excessive chemotaxis. Dysregulation of these brakes contributes to cancer, inflammation, and infection. Researchers can leverage CRISPR models and chemotaxis assays to dissect these pathways and identify therapeutic targets. EDITGENE provides comprehensive services to support such studies.
References
- 1. Patrussi L et al.. 2014. Negative regulation of chemokine receptor signaling and B-cell chemotaxis by p66Shc.. Cell Death Dis 5(2):e1068 PMID: 24556683
- 2. Fernandis AZ et al.. 2004. Regulation of CXCR4-mediated chemotaxis and chemoinvasion of breast cancer cells.. Oncogene 23(1):157-67 PMID: 14712221
- 3. Weiner OD. 2002. Regulation of cell polarity during eukaryotic chemotaxis: the chemotactic compass.. Curr Opin Cell Biol 14(2):196-202 PMID: 11891119
- 4. Koeppen M et al.. 2011. Purinergic regulation of airway inflammation.. Subcell Biochem 55:159-93 PMID: 21560048
- 5. Kundra V et al.. 1994. Regulation of chemotaxis by the platelet-derived growth factor receptor-beta.. Nature 367(6462):474-6 PMID: 8107807
- 6. Gao P et al.. 2005. Negative regulation of CXCR4-mediated chemotaxis by the lipid phosphatase activity of tumor suppressor PTEN.. Blood 106(8):2619-26 PMID: 15994292
- 7. Li N et al.. 2022. ARID1A loss induces polymorphonuclear myeloid-derived suppressor cell chemotaxis and promotes prostate cancer progression.. Nat Commun 13(1):7281 PMID: 36435834
- 8. Craven R et al.. 1985. Regulation of Pseudomonas aeruginosa chemotaxis by the nitrogen source.. J Bacteriol 164(2):544-9 PMID: 3932326
